US5215756A
(en)
*
|
1989-12-22 |
1993-06-01 |
Gole Dilip J |
Preparation of pharmaceutical and other matrix systems by solid-state dissolution
|
US5188825A
(en)
*
|
1989-12-28 |
1993-02-23 |
Iles Martin C |
Freeze-dried dosage forms and methods for preparing the same
|
GR910100193A
(el)
*
|
1991-05-03 |
1993-03-31 |
Mediventures Inc |
Παρασκευη φαρμακευτικων και αλλων περιβληματων με διαλυση σε στερεα κατασταση.
|
AU679906B2
(en)
*
|
1992-01-17 |
1997-07-17 |
Alfatec-Pharma Gmbh |
Solid bodies containing active substances and a structure consisting of hydrophilic macromolecules, plus a method of producing such bodies
|
US5840777A
(en)
*
|
1992-06-19 |
1998-11-24 |
Albany International Corp. |
Method of producing polysaccharide foams
|
CA2105887C
(en)
*
|
1992-09-10 |
2004-03-16 |
Peter Britton |
Bioerodible device for administering active ingredients
|
US5458884A
(en)
*
|
1992-09-10 |
1995-10-17 |
Britton; Peter |
Bioerodible device for administering active ingredients
|
GB9401892D0
(en)
*
|
1994-02-01 |
1994-03-30 |
Boots Co Plc |
Therapeutic agents
|
NO953115L
(no)
|
1995-06-07 |
1996-12-09 |
Albany Int Research |
Fremgangsmåte for fremstilling av polysakkaridskum
|
US5958589A
(en)
*
|
1995-07-07 |
1999-09-28 |
The United States Of America As Represented By The Secretary Of Agriculture |
Starch-based microcellular foams
|
US6165442A
(en)
*
|
1996-02-19 |
2000-12-26 |
Nycomed Imaging As |
Thermally stabilized ultrasound contrast agent
|
CZ262698A3
(cs)
*
|
1996-02-19 |
1999-03-17 |
Nycomed Imaging A/S |
Kontrastní prostředek pro zobrazování ultrazvukem a způsob jeho výroby
|
US5766520A
(en)
*
|
1996-07-15 |
1998-06-16 |
Universal Preservation Technologies, Inc. |
Preservation by foam formation
|
US6509146B1
(en)
|
1996-05-29 |
2003-01-21 |
Universal Preservation Technologies, Inc. |
Scalable long-term shelf preservation of sensitive biological solutions and suspensions
|
US5837286A
(en)
*
|
1997-01-15 |
1998-11-17 |
Pandya; Harish B. |
Taste masking for unplatable formulations
|
AU736912B2
(en)
|
1997-02-20 |
2001-08-02 |
Therics, Inc. |
Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same
|
US5976577A
(en)
*
|
1997-07-11 |
1999-11-02 |
Rp Scherer Corporation |
Process for preparing fast dispersing solid oral dosage form
|
AU8977698A
(en)
*
|
1997-07-25 |
1999-02-16 |
Elan Corporation, Plc |
A process for the preparation of a granulate suitable to the preparation of rapidly disintegrable mouth-soluble tablets
|
US5968362A
(en)
*
|
1997-08-04 |
1999-10-19 |
Controlled Enviromental Systems Corporation |
Method for the separation of acid from sugars
|
GB9717542D0
(en)
*
|
1997-08-19 |
1997-10-22 |
Nycomed Imaging As |
Process
|
US8236352B2
(en)
*
|
1998-10-01 |
2012-08-07 |
Alkermes Pharma Ireland Limited |
Glipizide compositions
|
US20040013613A1
(en)
*
|
2001-05-18 |
2004-01-22 |
Jain Rajeev A |
Rapidly disintegrating solid oral dosage form
|
US6090401A
(en)
*
|
1999-03-31 |
2000-07-18 |
Mcneil-Ppc, Inc. |
Stable foam composition
|
US6319510B1
(en)
|
1999-04-20 |
2001-11-20 |
Alayne Yates |
Gum pad for delivery of medication to mucosal tissues
|
US20040115134A1
(en)
*
|
1999-06-22 |
2004-06-17 |
Elan Pharma International Ltd. |
Novel nifedipine compositions
|
US6284270B1
(en)
|
1999-08-04 |
2001-09-04 |
Drugtech Corporation |
Means for creating a mass having structural integrity
|
US6316029B1
(en)
|
2000-05-18 |
2001-11-13 |
Flak Pharma International, Ltd. |
Rapidly disintegrating solid oral dosage form
|
EP1301177A2
(de)
*
|
2000-07-10 |
2003-04-16 |
Therics, Inc. |
Verfahren und materialien zur steuerung der wanderung einer binderflüssigkeit in ein pulver
|
US6982251B2
(en)
*
|
2000-12-20 |
2006-01-03 |
Schering Corporation |
Substituted 2-azetidinones useful as hypocholesterolemic agents
|
US6814978B2
(en)
|
2000-12-29 |
2004-11-09 |
Mcneil-Ppc, Inc. |
Process for preparing a soft tablet
|
DK1353694T3
(da)
*
|
2001-01-26 |
2008-03-25 |
Schering Corp |
Kombinationer af ezetimibe med aspirin til behandling af vaskulære tilstande
|
JP2004521894A
(ja)
*
|
2001-01-26 |
2004-07-22 |
シェーリング コーポレイション |
胆汁酸金属イオン封鎖剤およびステロール吸収阻害剤の併用および血管適応症の治療
|
US20060287254A1
(en)
*
|
2001-01-26 |
2006-12-21 |
Schering Corporation |
Use of substituted azetidinone compounds for the treatment of sitosterolemia
|
WO2002058696A2
(en)
*
|
2001-01-26 |
2002-08-01 |
Schering Corporation |
The use of substituted azetidinone compounds for the treatment of sitosterolemia
|
US7071181B2
(en)
*
|
2001-01-26 |
2006-07-04 |
Schering Corporation |
Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
|
AU2002247019C1
(en)
*
|
2001-01-26 |
2017-05-11 |
Organon Llc |
Combinations of peroxisome proliferator-activated receptor (PPAR) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
|
EP1541175A3
(de)
*
|
2001-01-26 |
2006-04-12 |
Schering Corporation |
Kombinationen von einem Hemmer der Sterol-Absorption und einem kardiovaskular Agent zur Behandlung von kardiovaskulären Indikationen
|
CA2434488A1
(en)
*
|
2001-01-26 |
2002-08-01 |
Harry R. Davis |
Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications
|
ATE345792T1
(de)
*
|
2001-05-25 |
2006-12-15 |
Schering Corp |
Verwendung von mit azetidinon substituierten derivaten bei der behandlung der alzheimer- krankheit
|
US20030153590A1
(en)
*
|
2001-08-14 |
2003-08-14 |
Oy Contral Pharma Ltd |
Method of treating alcoholism or alcohol abuse
|
US7056906B2
(en)
*
|
2001-09-21 |
2006-06-06 |
Schering Corporation |
Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
|
US7053080B2
(en)
*
|
2001-09-21 |
2006-05-30 |
Schering Corporation |
Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
|
US20030119808A1
(en)
*
|
2001-09-21 |
2003-06-26 |
Schering Corporation |
Methods of treating or preventing cardiovascular conditions while preventing or minimizing muscular degeneration side effects
|
HUP0401501A3
(en)
*
|
2001-09-21 |
2012-02-28 |
Schering Corp |
Treating or preventing vascular inflammation using pharmaceutical compositions containing sterol absorption inhibitor(s)
|
WO2003026643A2
(en)
*
|
2001-09-21 |
2003-04-03 |
Schering Corporation |
Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors
|
DK1443912T3
(da)
*
|
2001-10-12 |
2008-01-21 |
Elan Pharma Int Ltd |
Sammensætninger med en kombination af umiddelbare og kontrollerede frisætningsegenskaber
|
US20030180242A1
(en)
*
|
2001-11-01 |
2003-09-25 |
The Procter & Gamble Company |
Personal care compositions containing a water-disintegratable polymeric foam
|
US20030186826A1
(en)
*
|
2001-11-01 |
2003-10-02 |
The Procter & Gamble Company |
Method of using personal care compositions containing a high density, water disintegratable, polymeric foam
|
EP1941878A1
(de)
|
2002-01-10 |
2008-07-09 |
Biovail Laboratories International Srl |
Sedative Formulierungen ohne Benzodiazepin
|
CA2479735C
(en)
*
|
2002-03-20 |
2011-05-17 |
Elan Pharma International Ltd. |
Fast dissolving dosage forms having reduced friability
|
CA2482448C
(en)
*
|
2002-04-11 |
2014-07-08 |
Medimmune Vaccines, Inc. |
Preservation of bioactive materials by freeze dried foam
|
US20030215498A1
(en)
*
|
2002-05-17 |
2003-11-20 |
Harland Ronald S. |
Rapidly disintegrating comressed tablets comprising biologically active compounds
|
MXPA05004810A
(es)
*
|
2002-11-06 |
2005-07-22 |
Schering Corp |
Inhibidores de la absorcion del colesterol para el tratamiento de la desmielinizacion.
|
WO2004043440A1
(en)
*
|
2002-11-12 |
2004-05-27 |
Elan Pharma International Ltd. |
Fast-disintegrating solid dosage forms being not friable and comprising pullulan
|
US7459442B2
(en)
*
|
2003-03-07 |
2008-12-02 |
Schering Corporation |
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
|
EP1601669B1
(de)
*
|
2003-03-07 |
2008-12-24 |
Schering Corporation |
Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
|
US7192944B2
(en)
*
|
2003-03-07 |
2007-03-20 |
Schering Corp. |
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
|
ES2311806T3
(es)
*
|
2003-03-07 |
2009-02-16 |
Schering Corporation |
Compuesto de azetidinona sustituidos, fornulaciones y usos de los mismos para el tratamiento de hipercolesterolemia.
|
US20050036977A1
(en)
*
|
2003-08-11 |
2005-02-17 |
Dilip Gole |
Taste-masked resinate and preparation thereof
|
WO2005046797A2
(en)
*
|
2003-11-05 |
2005-05-26 |
Schering Corporation |
Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions
|
US7670624B2
(en)
*
|
2004-01-29 |
2010-03-02 |
Astella Pharma Inc. |
Gastrointestinal-specific multiple drug release system
|
US20050186271A1
(en)
*
|
2004-02-24 |
2005-08-25 |
Sheskey Paul J. |
Process for dispersing a fluid in a mass of solid particles
|
KR101264444B1
(ko)
|
2004-09-21 |
2013-05-20 |
히프니언 인크. |
록사핀 유사체 및 이것의 사용 방법
|
EP2388263A1
(de)
|
2005-08-04 |
2011-11-23 |
Sirtris Pharmaceuticals, Inc. |
Imidazo[2,1-b]thiazol-Derivate als Sirtuin-Modulatoren
|
JP4945157B2
(ja)
*
|
2006-03-27 |
2012-06-06 |
株式会社東芝 |
復元力に優れた再生可能な発泡成形体およびその製造方法ならびにその再生方法
|
JP2007262282A
(ja)
*
|
2006-03-29 |
2007-10-11 |
Toshiba Corp |
吸音材料およびその製造方法、ならびに吸音材料の再生方法
|
US20070243248A1
(en)
*
|
2006-04-14 |
2007-10-18 |
Cherukuri S Rao |
Rapidly disintegrating solid oral dosage form of liquid dispersions
|
WO2007130373A2
(en)
*
|
2006-05-01 |
2007-11-15 |
Capricorn Pharma, Inc. |
Novel triptan formulations and methods for making them
|
EP1870649A1
(de)
*
|
2006-06-20 |
2007-12-26 |
Octapharma AG |
Gefriertocknung zum Erzielen einer bestimmte Restfeuchte durch beschränkte Desorptionsenergiepegeln.
|
PT2041071E
(pt)
|
2006-06-29 |
2014-09-23 |
Kinex Pharmaceuticals Llc |
Composições de biarilo e processos para a regulação de uma cascata de cinases
|
US20090060983A1
(en)
*
|
2007-08-30 |
2009-03-05 |
Bunick Frank J |
Method And Composition For Making An Orally Disintegrating Dosage Form
|
AU2008314569B2
(en)
|
2007-10-20 |
2014-10-02 |
Atnx Spv, Llc |
Pharmaceutical compositions for modulating a kinase cascade and methods of use thereof
|
CA2704209C
(en)
*
|
2007-10-31 |
2017-02-28 |
Mcneil-Ppc, Inc. |
Orally disintegrative dosage form
|
CN101482359B
(zh)
*
|
2009-02-11 |
2010-04-14 |
中国农业科学院植物保护研究所 |
一种孢子粉干燥方法
|
US8980229B2
(en)
|
2009-04-01 |
2015-03-17 |
Colgate-Palmolive Company |
Dentifrice compositions and methods for treating and preventing damage to tooth surfaces
|
US8871263B2
(en)
*
|
2009-09-24 |
2014-10-28 |
Mcneil-Ppc, Inc. |
Manufacture of tablet in a die utilizing radiofrequency energy and meltable binder
|
US8858210B2
(en)
|
2009-09-24 |
2014-10-14 |
Mcneil-Ppc, Inc. |
Manufacture of variable density dosage forms utilizing radiofrequency energy
|
US8313768B2
(en)
|
2009-09-24 |
2012-11-20 |
Mcneil-Ppc, Inc. |
Manufacture of tablet having immediate release region and sustained release region
|
US20110070286A1
(en)
*
|
2009-09-24 |
2011-03-24 |
Andreas Hugerth |
Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said process
|
TR201002084A1
(tr)
|
2010-03-19 |
2011-10-21 |
Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ |
Oral yolla dağılan donepezil tablet formülasyonları ve hazırlama yöntemi
|
EP2377522B1
(de)
|
2010-04-15 |
2013-01-16 |
Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi |
Formulierungen von im Mund zerfallenden Mirtazapintabletten und Herstellungsverfahren dafür.
|
MX2013002430A
(es)
|
2010-09-01 |
2013-07-22 |
Arena Pharm Inc |
Formas de dosis de disolucion de rápida de agonistas de 5-ht2c.
|
WO2012056319A1
(en)
|
2010-10-27 |
2012-05-03 |
Dynamix Pharmaceuticals Ltd. |
Sulfonamides for the modulation of pkm2
|
EP2655334B1
(de)
|
2010-12-22 |
2018-10-03 |
Eutropics Pharmaceuticals, Inc. |
Zusammensetzungen und verfahren zur behandlung von erkrankungen
|
US8900557B2
(en)
|
2010-12-30 |
2014-12-02 |
Jr Chem, Llc |
Dental cleaning composition
|
US9005635B2
(en)
|
2011-03-01 |
2015-04-14 |
The Procter & Gamble Company |
Articles and processes for making a porous disintegratable solid substrate for personal health care applications
|
WO2012122370A2
(en)
|
2011-03-08 |
2012-09-13 |
Eutropics Pharmaceuticals, Inc. |
Compositions and methods useful for treating diseases
|
WO2012160447A1
(en)
|
2011-05-25 |
2012-11-29 |
Dynamix Pharmaceuticals Ltd. |
3, 5 -diphenyl- substituted pyrazolines for the treatment of cancer, proliferative, inflammatory or autoimmune diseases
|
CA2837268C
(en)
|
2011-06-07 |
2020-05-12 |
Oren M. Becker |
Compositions and methods for modulating a kinase
|
EP2609911A1
(de)
|
2011-12-29 |
2013-07-03 |
Sanovel Ilac Sanayi ve Ticaret A.S. |
Neuartiges Verfahren zur Herstellung von oral zerfallenden Flurbiprofen-Formulierungen
|
CN102755253A
(zh)
*
|
2012-01-17 |
2012-10-31 |
海南卫康制药(潜山)有限公司 |
制造在相连的盛药皿包装内冷冻干燥片剂的方法
|
US9511028B2
(en)
|
2012-05-01 |
2016-12-06 |
Johnson & Johnson Consumer Inc. |
Orally disintegrating tablet
|
US9233491B2
(en)
|
2012-05-01 |
2016-01-12 |
Johnson & Johnson Consumer Inc. |
Machine for production of solid dosage forms
|
US9445971B2
(en)
|
2012-05-01 |
2016-09-20 |
Johnson & Johnson Consumer Inc. |
Method of manufacturing solid dosage form
|
US20150150869A1
(en)
|
2012-06-20 |
2015-06-04 |
Eutropics Pharmaceuticals, Inc. |
Methods and compositions useful for treating diseases involving bcl-2 family proteins with quinoline derivatives
|
SI2890680T1
(en)
|
2012-08-30 |
2018-08-31 |
Athenex, Inc. Conventus Building |
N- (3-FLUOROBENZYL) -2- (5- (4-MORFOLINOPHENYL) PIRIDIN-2-IL) ACETAMIDE AS PROTEIN TIROZINE KINASE PROTECTORS
|
EP2968181B1
(de)
|
2013-03-15 |
2019-10-16 |
Aprecia Pharmaceuticals LLC |
Schnell zerfallende darreichungsform von topiramat
|
US9339489B2
(en)
|
2013-03-15 |
2016-05-17 |
Aprecia Pharmaceuticals Company |
Rapid disperse dosage form containing levetiracetam
|
AU2014228990B2
(en)
|
2013-03-15 |
2017-02-02 |
Aprecia Pharmaceuticals LLC |
Rapid disperse dosage form containing levetiracetam
|
JP6463333B2
(ja)
|
2013-03-15 |
2019-01-30 |
アプレシア・ファーマスーティカルズ・カンパニー |
オキシカルバゼピンの急速分散性の剤形
|
WO2015105992A1
(en)
|
2014-01-10 |
2015-07-16 |
Mcneil-Ppc, Inc. |
Process for making tablet using radiofrequency and lossy coated particles
|
WO2017168174A1
(en)
|
2016-04-02 |
2017-10-05 |
N4 Pharma Uk Limited |
New pharmaceutical forms of sildenafil
|
WO2018002673A1
(en)
|
2016-07-01 |
2018-01-04 |
N4 Pharma Uk Limited |
Novel formulations of angiotensin ii receptor antagonists
|
TW202246254A
(zh)
|
2016-08-12 |
2022-12-01 |
美商亞瑟尼克斯公司 |
聯芳組成物和調控激酶級聯之方法
|
MX2019004238A
(es)
|
2016-10-13 |
2019-11-08 |
Catalent Uk Swindon Zydis Ltd |
Composiciones farmaceuticas liofilizadas para suministro vaginal.
|
WO2018115888A1
(en)
|
2016-12-21 |
2018-06-28 |
N4 Pharma Uk Limited |
Novel formulations of aprepitant
|
US10493026B2
(en)
|
2017-03-20 |
2019-12-03 |
Johnson & Johnson Consumer Inc. |
Process for making tablet using radiofrequency and lossy coated particles
|
CZ307916B6
(cs)
|
2017-05-08 |
2019-08-21 |
mcePharma s. r. o. |
Orodispergovatelná tableta s biodostupným kurkuminem a její použití
|
EP3883546A1
(de)
|
2018-11-21 |
2021-09-29 |
Rosemont Pharmaceuticals Ltd |
Orale topiramat-suspensionsformulierungen mit verlängerter lagerstabilität und verbesserter bioverfügbarkeit
|
US10758329B1
(en)
|
2019-08-20 |
2020-09-01 |
Raymond L. Wright, III |
Hydrating mouth guard
|
CN116018131A
(zh)
|
2020-06-26 |
2023-04-25 |
阿普雷奇亚制药有限责任公司 |
具有内腔的快速口腔分散片剂
|